AAHomecare Lists Problems with Competitive Bidding NPRM
WASHNGTON–AAHomecare recently outlined its top concerns with
CMS’ competitive bidding Notice of Proposed Rulemaking, published
May 1 (see HomeCare
Monday, May 1). According to the association:
-
Getting it right is more important than rushing implementation.
CMS should stagger the bidding in MSAs in 2007 to allow for an
orderly roll-out. This would allow CMS to identify problems that
occur and correct them before they become widespread. Also, the
initial MSAs and products selected should be identified in the
final rule. And under the timeline CMS is proposing, small
providers will not have time to create networks, which eliminates
them as a practical option for small providers that want to
participate. -
Have accreditation and standards in place before starting. Only
accredited providers should be eligible to submit bids. CMS should
not proceed with competitive bidding until this is possible and
needs to identify the criteria it will use to identify the
accrediting bodies now. CMS should grandfather all providers
accredited by organizations that meet the criteria it identifies,
and should allow additional time for providers to analyze the
quality standards in conjunction with the proposed competitive
bidding rule. The quality standards will affect the cost of
servicing beneficiaries and are an integral part of the bid
process. -
Make competitive bidding competitive and sustainable. CMS should
not artificially limit bids by disqualifying bids above the current
fee schedule amount for an item. Otherwise, the competition is not
truly competitive based on market prices. Bid evaluation and the
selection of winning bidders should be designed to result in
pricing that is rational and sustainable. CMS has not identified
any process through which it will seek to determine that the bids
are either. -
Don’t make it harder for providers to sell their businesses. The
proposal to restrict the acquisition of a winning provider unless
CMS needs to replace the supplier’s capacity within the bidding
area places an inappropriate restriction on the provider’s property
rights. While it is appropriate for CMS to consider the buyer’s
quality and financial stability, CMS should not make approval of
the acquisition contingent on the need to preserve capacity within
the MSA. -
Consider the impact on the patient. CMS cannot rely solely on
costs and volume for product selection. Consider issues such as
access and medical necessity of beneficiaries who use the items.
Competitive bidding should not be a substitute for appropriate
medical policy.
Additional concerns include the NPRM’s composite score
methodology, the rebate program, product selection, the bid
process, how CMS will determine the number of suppliers needed to
meet demand in bidding areas, what measures will be used to figure
out the savings that would result from bidding on an item,
gap-filling and networks.
To view CMS’ Notice of Proposed Rulemaking on competitive
bidding,
click here.
For a summary of the proposed competitive bidding rule,
click here.
CMS is accepting comments on the proposal through June 30. To
comment, visit www.cms.hhs.gov/eRulemaking.
Post navigation
OUR DIGITAL PARTNERS


